A federal judge on Thursday declined to block the bankruptcy sale of genetic testing company 23andMe to its co-founder Anne ...

A $8 billion-dollar class action investors’ lawsuit against Meta CEO Mark Zuckerberg and company leaders begins, with claims ...

Famed investor Marc Andreessen is scheduled to take the stand on Thursday to defend his role on the Facebook board of ...

Regeneron Pharmaceuticals sees strength in Dupixent, oncology gains, and major buybacks despite setbacks. Find out why REGN ...

A court battle between two of the nation’s largest biotechs is testing the legal limits of how far drugmakers can go in using ...

A court battle between Regeneron and Amgen is testing the legal limits of how far drugmakers can go in using patents to ...

Former President Joe Biden's chief of staff was on the witness stand in Wilmington defending his work on Facebook's board of directors.

US-based MAIA Biotechnology has dosed the first subject in Taiwan in the expansion phase of its multicentre THIO-101 Phase II ...

The communications, community engagement and compliance tech company has launched its first AI chatbot, and the company’s CEO ...

And security spending is likely to climb in 2025 following the fatal shooting of UnitedHealthcare CEO Brian Thompson in December 2024. Experts say heightened security resources correlate to a rise in ...

The results position Hengrui to seek approval of the Zepbound-like drug in China and Kailera, a well-funded biotech startup, ...